DeepX Health’s Skin Cancer Teledermoscopy Services Now in Jersey

On skin cancer awareness month this May, our teledermoscopy services have become available in the first pharmacy in Jersey. We are proud to partner with Reids Pharmacy to enable the ScreenCancer teledermoscopy service, to streamline and fast-track skin cancer diagnosis in new communities, however remote.


Skin cancer is the most prevalent cancer in the world, and melanoma is the most fatal of skin cancer types, with over 300,000 patients diagnosed and over50,000 deaths in 2020. Early detection of skin cancer is vital. In fact, localized skin cancer lesions can be easily removed, whereas once in metastatic phase, skin cancer is unfortunately fatal for most patients.


DeepX Health’s offers teledermoscopy services in over 280 community pharmacies, primary care practices and aesthetic clinics in UK and Europe. Our service allows accessible and prompt scanning of suspicious lesions and early detection of skin cancer. Our teledermoscopy service is delivered through DeepX Health’s DermoSight dermatoscopic tool. Our network of dermatology specialists reviews the images remotely and provide an expert and confidential diagnosis.


“We are proud to be the first pharmacy offering such a vital and affordable service to our community in Jersey. Scanning suspect lesions in the pharmacy spares the patients unnecessary visits and long waits to see a dermatologist and can help fast-track treatment for those lesions that require further attention,” said Nicki Reid, Director at the Jersey pharmacy chain.

July 11, 2023

DeepX Health’s DermoSight featured on BBC

Read more

July 10, 2023

DeepX Health’s DermoSight at NHS event on 12 July

Read more

June 6, 2023

DeepX Diagnostics Inc.'s DermoSight Receives FDA Clearance for Teledermatology Screening of Suspect Skin Cancer Lesions

Read more

November 29, 2021

New Board Advisor to DeepX Health

Read more

March 30, 2021

New Head of Product at DeepX Health

Read more

March 15, 2021

DeepX Health selected to present at Nordic Life Science Days

Read more

December 15, 2020

Pharmacy Screening Demonstrates Great Efficiency and Potential for Cost Reductions

Read more

October 23, 2020

Primary Care Setting Pilot Launched with NHS

Read more

October 14, 2020

DeepX Health to Present at the 8th World Congress of Teledermatology, Imaging and Artificial Intelligence for Skin Diseases

Read more

September 30, 2020

ScreenCancer Awarded Support for Diagnostic Triage Algorithm-Project

Read more

January 8, 2020

DeepX Health to participate at the 7th Annual Dermatology Summit in San Francisco

Read more

December 13, 2019

DeepX Health to present at Digital Health World Congress in London

Read more

December 3, 2019

DeepX Health participate in the DxPx Conference

Read more

December 1, 2019

ScreenCancer approved for first round of Horizon 2020 programme

Read more